Blog
Board of Directors Welcomes Jim Davis
We are excited to welcome Jim Davis to the FSR Board of Directors. Jim is the Executive Vice President of Advera Health Analytics, Inc. He has over 12 years of expertise in biopharma market research, intelligence, and data. FSR looks forward to the impact Jim can have...
One-Question Survey: Future Clinical Trial for Pulmonary Sarc
Dear Pulmonary Sarcoidosis Patient, FSR is reaching out with our partner Transparency Life Sciences to ask if you would be interested in a future clinical trial of a new drug candidate for pulmonary sarcoidosis. This trial would test the drug Kiacta (eprodisate), an...